Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 159

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long‐term oestrogen–progestagen treatment

Pasquali, Renato, Gambineri, Alessandra, Anconetani, Bruno, Vicennati, Valentina, Colitta, Donatella, Caramelli, Elisabetta, Casimirri, Francesco, Morselli‐Labate, Antonio Maria·1999·Clinical Endocrinology

Abstract

OBJECTIVE: Little is known about the natural history of polycystic ovary syndrome (PCOS), although preliminary data indicate that affected women are more susceptible than the general population to diabetes and cardiovascular diseases at post‐menopausal ages. The aim of this study was to follow‐up all main features of the metabolic syndrome in a group of young women with PCOS and to investigate the long‐term effects on metabolism and body composition of oestrogen–progestagen (OP) compounds, which are frequently used in these women to treat hyperandrogenism and related clinical features. DESIGN: Long‐term follow‐up study. SUBJECTS AND METHODS: Thirty‐seven women with PCOS were re‐evaluated 10.3 ± 0.8 years (range 6–18 years) after their first assessments (age: before 19.8 ± 4.9 years; after 29.9 ± 4.4 years). When first examined, women were instructed to follow a hypocaloric diet if they were obese plus OP, if they agreed to such treatment. Main anthropometric parameters, basal sex hormones and lipids, fasting and glucose‐stimulated glucose and insulin levels and several clinical data were recorded before and after follow‐up. RESULTS: In the whole group of women with PCOS we found no changes in body weight and fat mass, whereas both the waist‐to‐hip ratio and the waist‐to‐thigh ratio were significantly reduced. No significant changes occurred in mean fasting and glucose‐ stimulated glucose and insulin concentrations, whereas a significant increase in high‐density lipoprotein– cholesterol was found. No significant changes occurred in testosterone levels. During the follow‐up period 16 women took OP for an average of 97 ± 18 months (range 12–180 months) (OP‐users) whereas 21 women never took OP (non‐OP‐users). All OP‐users were still taking OP when re‐evaluated at the follow‐up examination. With respect to baseline values, body mass index was higher in non‐OP‐users than in their counterparts. Waist circumference (P < 0.025), the waist‐to‐hip (P < 0.05) and the waist‐to‐thigh (P < 0.01) ratios decreased significantly only in the OP‐users. In addition, percentage changes in waist circumference (P < 0.05) and waist‐to‐hip ratio (P < 0.05) during the follow‐up period were significantly different between the groups. Glucose tolerance (as area under the curve (AUC)) improved (P < 0.05) in OP‐users but not in non‐OP‐users. Moreover, compared to baseline values, basal insulin levels were significantly (P < 0.01) reduced in OP‐users but not in non‐OP‐users. On the contrary, no significant change was found in insulin AUC in the former, whereas it significantly increased (P < 0.05) in the latter. Accordingly, fasting C‐peptide decreased (P < 0.05) in OP‐users, whereas both fasting (P < 0.01) and stimulated (P < 0.01) C‐ peptide significantly increased in non‐OP‐users. Changes in fasting or stimulated insulin and C‐peptide in non‐OP‐users were not associated with parallel changes in testosterone levels. Total cholesterol and triglycerides did not change in either group, but HDL‐cholesterol increased (P < 0.05) only in OP‐users. Sex hormone‐binding globulin concentrations increased significantly (P < 0.01) in OP‐users, without any significant change in non‐OP‐users. Testosterone concentrations did not change significantly in either group, but the testosterone : SHBG ratio significantly decreased in OP‐users (P < 0.05) but not in the non‐OP‐users. Among the clinical features, acanthosis nigricans significantly (P < 0.01) worsened in non‐OP‐users but not in the OP‐users, without any significant change in the hirsutism and acne scores. Pregnancy rates during the follow‐up were similar in both groups. CONCLUSIONS: These data indicate that hyperinsulinaemia and insulin resistance tended to worsen spontaneously in women with PCOS, without any worsening of the hyperandrogenism. Long‐term oestrogen–progestagen treatment countered this tendency, probably because it improved the pattern of body fat distribution, by reducing abdominal fat depots.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2265.1999.00701.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 159

Metadata

Authors
Pasquali, R., Gambineri, A., Anconetani, B., Vicennati, V., Colitta, D., Caramelli, E., Casimirri, F., & Morselli‐Labate, A. M.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1999-04
Volume
50
Issue
4
Pages
517-527
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2062244462
Cited by
159
References
9
FWCI
6.52
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long‐term oestrogen–progestagen treatment. https://app.cochat.ai/papers/10.1046/j.1365-2265.1999.00701.x
The paper
Pasquali, R., Gambineri, A., Anconetani, B., Vicennati, V., Colitta, D., Caramelli, E., Casimirri, F., & Morselli‐Labate, A. M. (1999). The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long‐term oestrogen–progestagen treatment. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.1999.00701.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.